| 27.76 0.7 (2.59%) | 10-15 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 32.45 |
1-year : | 37.91 |
| Resists | First : | 27.79 |
Second : | 32.45 |
| Pivot price | 26.32 |
|||
| Supports | First : | 26.17 |
Second : | 25.18 |
| MAs | MA(5) : | 26.99 |
MA(20) : | 26.22 |
| MA(100) : | 25.57 |
MA(250) : | 23.07 |
|
| MACD | MACD : | 0.2 |
Signal : | 0 |
| %K %D | K(14,3) : | 87.6 |
D(3) : | 85.3 |
| RSI | RSI(14): 65.6 |
|||
| 52-week | High : | 27.94 | Low : | 16.02 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ MD ] has closed Bollinger Bands are 10.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 27.82 - 27.93 | 27.93 - 28.01 |
| Low: | 27 - 27.14 | 27.14 - 27.24 |
| Close: | 27.56 - 27.77 | 27.77 - 27.93 |
Pediatrix Medical Group, Inc. delivers specialized medical services for newborns, expectant mothers, and pediatric patients across the United States and Puerto Rico. The company offers crucial neonatal care to critically ill or prematurely born infants within hospital units, staffed by expert neonatal subspecialists and advanced practice clinicians. For pregnant individuals and their developing babies, Pediatrix provides comprehensive maternal-fetal medicine services in both clinical and inpatient settings, involving specialists such as maternal-fetal medicine physicians, obstetricians, and genetic counselors. Furthermore, the group delivers pediatric cardiology services, addressing both congenital and acquired heart conditions in patients ranging from the fetal stage through adulthood, under the care of dedicated pediatric cardiologists. Beyond these core areas, Pediatrix extends its expertise to various other pediatric subspecialties, including those requiring intensivists, surgeons, and ophthalmologists, and supplies vital support to hospital departments like emergency rooms and labor and delivery units. Established in 1979 in Sunrise, Florida, and formerly known as MEDNAX, Inc. until its renaming in July 2022, the company managed a network of approximately 2,700 physicians as of February 2022.
Thu, 15 Oct 2026
Pediatrix Medical Group (MD) Gains On Quarterly Results, Is The Valuation Already Priced In? - Simply Wall Street
Thu, 15 Oct 2026
Pediatrix Medical Group, Inc. (MD) Stock forecasts - Yahoo Finance UK
Thu, 15 Oct 2026
Pediatrix Medical Group, Inc. (MD) Stock Forecasts - Yahoo Finance
Wed, 14 Oct 2026
Pediatrix Medical Group, Inc. (MD) Stock Price, News, Quote & History - Yahoo! Finance Canada
Wed, 14 Oct 2026
3 Reasons MD is Risky and 1 Stock to Buy Instead - FinancialContent
Tue, 22 Sep 2026
Can Pediatrix Sustain Growth Despite Lower Patient Volumes? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 81 (M) |
| Shares Float | 78 (M) |
| Held by Insiders | 2 (%) |
| Held by Institutions | 107.4 (%) |
| Shares Short | 4,610 (K) |
| Shares Short P.Month | 4,820 (K) |
| EPS | 2.11 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 11.1 |
| Profit Margin | 8.9 % |
| Operating Margin | 13.4 % |
| Return on Assets (ttm) | 7.1 % |
| Return on Equity (ttm) | 20.3 % |
| Qtrly Rev. Growth | 4 % |
| Gross Profit (p.s.) | 6.29 |
| Sales Per Share | 24 |
| EBITDA (p.s.) | 3.24 |
| Qtrly Earnings Growth | 6.5 % |
| Operating Cash Flow | 247 (M) |
| Levered Free Cash Flow | 161 (M) |
| PE Ratio | 13.09 |
| PEG Ratio | 0.2 |
| Price to Book value | 2.49 |
| Price to Sales | 1.15 |
| Price to Cash Flow | 9.13 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|